Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04243941
What this trial is testing

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03815942
What this trial is testing

VAccination in Early and ADvanced Prostate caNCEr

Who this might be right for
Intermediate Risk Prostate CancerCastration-resistant Prostate Cancer
University of Oxford 23
Large-scale testing (Phase 3)Study completedNCT00104741
What this trial is testing

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 378
Not applicableUnknownNCT01478412
What this trial is testing

An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
John Chang, MD 20
Not applicableLooking for participantsNCT06945172
What this trial is testing

Comparison of Prostate Cancer-related Quality of Life in Sexually Active Men With Favourable Intermediate-risk Localised Prostate Cancer Treated With Total Prostatectomy or Focal HIFU

Who this might be right for
Prostate Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche 102
Large-scale testing (Phase 3)Study completedNCT02919111
What this trial is testing

Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients

Who this might be right for
Prostate Cancer
University of California, San Francisco 299
Not applicableLooking for participantsNCT07115992
What this trial is testing

Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%

Who this might be right for
Prostate CancerProstate Adenoma
Ruijin Hospital 270
Large-scale testing (Phase 3)Study completedNCT02678351
What this trial is testing

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Andrei Iagaru 74
Not applicableLooking for participantsNCT05710861
What this trial is testing

Cost-utility of Focal HIFU vs Prostatectomy

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 346
Testing effectiveness (Phase 2)Looking for participantsNCT06772441
What this trial is testing

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Who this might be right for
Prostate Cancer
German Oncology Center, Cyprus 30
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02923180
What this trial is testing

Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Not applicableEnded earlyNCT03290508
What this trial is testing

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 524
Not applicableNot Yet RecruitingNCT07747493
What this trial is testing

68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy

Who this might be right for
Prostate Cancer (Adenocarcinoma)Localized Prostate Cancer
University Health Network, Toronto 8
Not applicableStudy completedNCT01985828
What this trial is testing

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Wake Forest University Health Sciences 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT00525720
What this trial is testing

Brachytherapy for Prostatic Carcinoma Patients

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 300
Not applicableActive Not RecruitingNCT02723734
What this trial is testing

Validation Study on the Impact of Decipher® Testing - VANDAAM Study

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 240
Not applicableEnded earlyNCT02968784
What this trial is testing

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
InSightec 53
Early research (Phase 1)Study completedNCT00450229
What this trial is testing

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateProstate CancerStage I Prostate Cancer+1 more
National Cancer Institute (NCI) 45
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Next Page